论文部分内容阅读
目的观察急性心肌梗死患者静脉溶栓治疗的疗效及预后。方法对42例确诊为AMI且符合溶栓条件的患者进行溶栓以及规范化治疗,并进行对症处理。结果 42例患者中22例发病6h内溶栓,其中21例溶解,1例未通;20例患者发病6～24h溶栓,其中15例溶解,5例未通;再通者中1例因反复梗死并发心力衰竭而死亡,1例因室颤死亡。结论尿激酶静脉溶栓治疗安全、有效,价格便宜,是急性心肌梗死的一种有效治疗方法。
Objective To observe the curative effect and prognosis of intravenous thrombolysis in patients with acute myocardial infarction. Methods Thirty-two patients who were diagnosed as AMI and were eligible for thrombolytic therapy were treated with thrombolysis and standard therapy, and symptomatic treatment was performed. Results Twenty-two of 42 patients developed thrombolysis within 6 hours, of which 21 cases were dissolved and 1 case failed. Thrombolytic therapy was given in 20 cases in 6 to 24 hours, of which 15 cases were dissolved and 5 cases failed. One case of recanalization Repeated infarction complicated by heart failure and death, 1 patient died of ventricular fibrillation. Conclusions Urokinase intravenous thrombolysis is safe, effective and cheap, and it is an effective treatment for acute myocardial infarction.